Display Settings:

Format

Send to:

Choose Destination
    Cephalalgia. 1992 Apr;12(2):81-4.

    Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo.

    Source

    Department of Neurology, Beilinson Medical Center, Petach Tikva, Israel.

    Abstract

    The efficacy of sodium valproate (Depalept) versus placebo in the treatment of migraine was evaluated in a double-blind randomized cross-over study in twenty-nine patients. The patients were divided into two groups each of which was alternately given 400 mg of sodium valproate B.I.d or placebo for eight weeks and then crossed over for an additional eight weeks. Our results show that in 86.2% of the patients sodium valproate was effective in preventing migraine or reducing the frequency, severity and duration of the attacks. In general, the drug was well tolerated and proved to be an effective treatment in migraine.

    PMID:
    1576648
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk